While the US remains the supreme destination, local biotechs and investors are scouring for untapped opportunities elsewhere. ... Read More The post Biocurious: from Türkiye to Tashkent, biotechs ...
A 42-year-old construction worker sits across from me in clinic, MRI in hand, convinced he needs surgery. His primary care ...